411 related articles for article (PubMed ID: 33413517)
1. Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD.
Kumar S; Phaneuf D; Cordeau P; Boutej H; Kriz J; Julien JP
Mol Neurodegener; 2021 Jan; 16(1):1. PubMed ID: 33413517
[TBL] [Abstract][Full Text] [Related]
2. Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration.
Dutta K; Patel P; Rahimian R; Phaneuf D; Julien JP
Neurotherapeutics; 2017 Apr; 14(2):447-462. PubMed ID: 27928708
[TBL] [Abstract][Full Text] [Related]
3. Modelling TDP-43 proteinopathy in Drosophila uncovers shared and neuron-specific targets across ALS and FTD relevant circuits.
Godfrey RK; Alsop E; Bjork RT; Chauhan BS; Ruvalcaba HC; Antone J; Gittings LM; Michael AF; Williams C; Hala'ufia G; Blythe AD; Hall M; Sattler R; Van Keuren-Jensen K; Zarnescu DC
Acta Neuropathol Commun; 2023 Oct; 11(1):168. PubMed ID: 37864255
[TBL] [Abstract][Full Text] [Related]
4. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy.
Matsukawa K; Kukharsky MS; Park SK; Park S; Watanabe N; Iwatsubo T; Hashimoto T; Liebman SW; Shelkovnikova TA
RNA Biol; 2021 Nov; 18(11):1546-1554. PubMed ID: 33427561
[TBL] [Abstract][Full Text] [Related]
6. The era of cryptic exons: implications for ALS-FTD.
Mehta PR; Brown AL; Ward ME; Fratta P
Mol Neurodegener; 2023 Mar; 18(1):16. PubMed ID: 36922834
[TBL] [Abstract][Full Text] [Related]
7. Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Chan Moi Fat S; Wu SS; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S
J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):162-171. PubMed ID: 31690696
[TBL] [Abstract][Full Text] [Related]
8. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.
Walker AK; Spiller KJ; Ge G; Zheng A; Xu Y; Zhou M; Tripathy K; Kwong LK; Trojanowski JQ; Lee VM
Acta Neuropathol; 2015 Nov; 130(5):643-60. PubMed ID: 26197969
[TBL] [Abstract][Full Text] [Related]
9. Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43
Bargsted L; Medinas DB; Martínez Traub F; Rozas P; Muñoz N; Nassif M; Jerez C; Catenaccio A; Court FA; Hetz C; Matus S
Sci Rep; 2017 Oct; 7(1):14266. PubMed ID: 29079747
[TBL] [Abstract][Full Text] [Related]
10. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs.
Lagier-Tourenne C; Polymenidou M; Hutt KR; Vu AQ; Baughn M; Huelga SC; Clutario KM; Ling SC; Liang TY; Mazur C; Wancewicz E; Kim AS; Watt A; Freier S; Hicks GG; Donohue JP; Shiue L; Bennett CF; Ravits J; Cleveland DW; Yeo GW
Nat Neurosci; 2012 Nov; 15(11):1488-97. PubMed ID: 23023293
[TBL] [Abstract][Full Text] [Related]
11. Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling.
Dutta K; Thammisetty SS; Boutej H; Bareil C; Julien JP
J Neurosci; 2020 Jun; 40(26):5137-5154. PubMed ID: 32457070
[TBL] [Abstract][Full Text] [Related]
12. Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD.
Hayes LR; Kalab P
Neurotherapeutics; 2022 Jul; 19(4):1061-1084. PubMed ID: 35790708
[TBL] [Abstract][Full Text] [Related]
13. TDP-43 proteinopathy alters the ribosome association of multiple mRNAs including the glypican Dally-like protein (Dlp)/GPC6.
Lehmkuhl EM; Loganathan S; Alsop E; Blythe AD; Kovalik T; Mortimore NP; Barrameda D; Kueth C; Eck RJ; Siddegowda BB; Joardar A; Ball H; Macias ME; Bowser R; Van Keuren-Jensen K; Zarnescu DC
Acta Neuropathol Commun; 2021 Mar; 9(1):52. PubMed ID: 33762006
[TBL] [Abstract][Full Text] [Related]
14. Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy.
Khalil B; Chhangani D; Wren MC; Smith CL; Lee JH; Li X; Puttinger C; Tsai CW; Fortin G; Morderer D; Gao J; Liu F; Lim CK; Chen J; Chou CC; Croft CL; Gleixner AM; Donnelly CJ; Golde TE; Petrucelli L; Oskarsson B; Dickson DW; Zhang K; Shorter J; Yoshimura SH; Barmada SJ; Rincon-Limas DE; Rossoll W
Mol Neurodegener; 2022 Dec; 17(1):80. PubMed ID: 36482422
[TBL] [Abstract][Full Text] [Related]
15. Disease animal models of TDP-43 proteinopathy and their pre-clinical applications.
Liu YC; Chiang PM; Tsai KJ
Int J Mol Sci; 2013 Oct; 14(10):20079-111. PubMed ID: 24113586
[TBL] [Abstract][Full Text] [Related]
16. TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons.
Nagano S; Jinno J; Abdelhamid RF; Jin Y; Shibata M; Watanabe S; Hirokawa S; Nishizawa M; Sakimura K; Onodera O; Okada H; Okada T; Saito Y; Takahashi-Fujigasaki J; Murayama S; Wakatsuki S; Mochizuki H; Araki T
Acta Neuropathol; 2020 Nov; 140(5):695-713. PubMed ID: 32803350
[TBL] [Abstract][Full Text] [Related]
17. Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology.
Pozzi S; Thammisetty SS; Codron P; Rahimian R; Plourde KV; Soucy G; Bareil C; Phaneuf D; Kriz J; Gravel C; Julien JP
J Clin Invest; 2019 Feb; 129(4):1581-1595. PubMed ID: 30667370
[TBL] [Abstract][Full Text] [Related]
18. TDP-43 stabilizes G3BP1 mRNA: relevance to amyotrophic lateral sclerosis/frontotemporal dementia.
Sidibé H; Khalfallah Y; Xiao S; Gómez NB; Fakim H; Tank EMH; Di Tomasso G; Bareke E; Aulas A; McKeever PM; Melamed Z; Destroimaisons L; Deshaies JE; Zinman L; Parker JA; Legault P; Tétreault M; Barmada SJ; Robertson J; Vande Velde C
Brain; 2021 Dec; 144(11):3461-3476. PubMed ID: 34115105
[TBL] [Abstract][Full Text] [Related]
19. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy.
Chew J; Cook C; Gendron TF; Jansen-West K; Del Rosso G; Daughrity LM; Castanedes-Casey M; Kurti A; Stankowski JN; Disney MD; Rothstein JD; Dickson DW; Fryer JD; Zhang YJ; Petrucelli L
Mol Neurodegener; 2019 Feb; 14(1):9. PubMed ID: 30767771
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.
Wood A; Gurfinkel Y; Polain N; Lamont W; Lyn Rea S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
